The Motley Fool

Key Data Points

Primary metrics and data points about Provectus Pharmaceuticals, Inc..
Current Price: $0.89
Prev Close: $0.92
Open: $0.93
Bid: $0.85
Ask: $0.99
Day's Range: $0.88 - $0.93
52wk Range: $0.30 - $3.75
Volume: 165,152
Avg Vol 285,419
Market Cap: $164M
P/E (ttm): -15.33
EPS (ttm): ($0.06)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Provectus Pharmaceuticals, Inc. from Fool.com.

Business Summary

Industry, sector and description for Provectus Pharmaceuticals, Inc..

A development-stage biopharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

PVCT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Provectus Pharmaceuticals, Inc..
CAPS Rating 1 out of 5
 
35 Outperform
47 Underperform
CAPS All Stars
 
8 Outperform
35 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

H. Craig Dees, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Provectus Pharmaceuticals, Inc.

Primary metrics and data points about Provectus Pharmaceuticals, Inc..